These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 1383125)

  • 1. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
    Tamm A; Schmidt RE
    J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against synthetic sequences of the nicotinic receptor cross-react fully with the native receptor and reveal the transmembrane disposition of their epitopes.
    Lei S; Raftery MA; Conti-Tronconi BM
    Biochemistry; 1993 Jan; 32(1):91-100. PubMed ID: 7678197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against a synthetic peptide from human immunodeficiency virus type 1 Nef protein.
    Steinaa L; Wulff AM; Saermark T
    Hybridoma; 1994 Oct; 13(5):383-8. PubMed ID: 7860095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of monoclonal antibodies recognising different epitopes present on insulin-like growth factor 1.
    Harvey D; Jones WT; Jones SD; Ryan GB
    Hybridoma; 1993 Dec; 12(6):737-44. PubMed ID: 7507085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production and characterization of the monoclonal antibodies against nonstructural 1 protein of DENV-4].
    Ding XX; DI B; Che XY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):777-9. PubMed ID: 21722533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies raised against peptide fragments of CD16 reacting with membrane and soluble form of CD16. I: Production and characterization.
    Mouawad R; Visonneau S; Soubrane C; Hirel PH; Autran B; Marceau-Suissa J; Weil M; Khayat D
    Hybridoma; 1992 Aug; 11(4):447-59. PubMed ID: 1383125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.
    Moldovan I; Galon J; Maridonneau-Parini I; Roman Roman S; Mathiot C; Fridman WH; Sautès-Fridman C
    Immunol Lett; 1999 May; 68(1):125-34. PubMed ID: 10397167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD16 in plasma cell dyscrasias.
    Mathiot C; Galon J; Tartour E; Teillaud JL; Facon T; Bataille R; Fridman WH; Sautès C
    Leuk Lymphoma; 1999 Feb; 32(5-6):467-74. PubMed ID: 10048419
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.